- Home
- ENTX vs SHMD Comparison
ENTX vs SHMD Comparison
Compare ENTX & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ENTX | SHMD |
|---|---|---|
| Founded | 2010 | 1864 |
| Country | Israel | Germany |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.2M | 323.0M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | ENTX | SHMD |
|---|---|---|
| Price | $1.13 | $5.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | 156.9K | ★ 828.9K |
| Earning Date | 05-08-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $181,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $5.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.98 | $2.00 |
| 52 Week High | $3.22 | $10.65 |
Technical Indicators
Market Signals| Indicator | ENTX | SHMD |
|---|---|---|
| Relative Strength Index (RSI) | 41.35 | 42.37 |
| Support Level | $1.00 | $5.75 |
| Resistance Level | $1.61 | $6.70 |
| Average True Range (ATR) | 0.16 | 0.71 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 20.33 | 5.95 |
Price Performance
Historical ComparisonAbout ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
About SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).